The road ahead

Where we are.
What we’re up to.

Where we are.
What we’re up to.

We have an ambitious pipeline that is targeting indications of highest medical need and with a significant market potential.

In-vitro PoC

In-vivo PoC

IND-enabling studies

FIH

Oncology

seRNA 001 HCC

Seed Milestones

seRNA 002 Lung cancer

Seed Milestones

seRNA 003 Glioblastoma

Open for partnerships

Non-Oncology

seRNA 004 Viral diseases

Undisclosed

seRNA 005 Autoimmune Diseases

Undisclosed

See what’s going on right now!